Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Pharma
Mayo, InSitu pen prolonged-release cancer co-development pact
The agreement gives Mayo a financial interest in InSitu Biologics and its prolonged-release drug delivery platform technology.
Nick Paul Taylor
Jan 3, 2023 7:15am
Selecta taps Ginkgo to improve gene therapy delivery
Jan 11, 2022 9:40am
Iacta bags rights to Tallc's pan-ocular drug delivery technology
Dec 21, 2021 8:55am
Seelos eyes chronic ketamine dosing with sublingual candidate
Nov 30, 2021 9:45am
Takeda, JCR ink deal to commercialize Hunter syndrome drug
Sep 30, 2021 10:35am
Théa inks $135M deal for EU rights to Nevakar's myopia eye drops
Feb 2, 2021 7:15am
